Chibana Yoko, Fujii Shigehiko, Ichikawa Kazuhito, Fujita Mikio, Ono Yuko, Tomita Shigeki, Imura Johji, Kawamata Hitoshi, Terano Akira, Fujimori Takahiro
Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, Japan.
J Gastroenterol Hepatol. 2005 Sep;20(9):1371-8. doi: 10.1111/j.1440-1746.2005.03858.x.
It is still not clear which parameters are important for predicting the metastatic potential of superficial esophageal squamous cell carcinoma (SESCC). The purpose of the present paper was thus to investigate tumor cell dissociation (TCD) in SESCC as a predictive factor of lymph node metastasis.
Thirty-three SESCC were classified into four groups based on the depth of tumor invasion. Carcinomas not invading as far as the muscularis mucosa were classified as group A; carcinomas invading to the muscularis mucosa or less than one-third of the upper submucosa were classified as group B; those invading to the middle layer of the submucosa were classified as group C; and those invading one-third of the lower submucosa were classified as group D. The TCD score was calculated by dividing the length of the TCD region by the maximal longitudinal length of the area of invasion into or beyond the lamina propria, and multiplying by 100. E-cadherin expression of the carcinomas was investigated in the TCD area and the successive area of mucosal invasive carcinoma (SAM).
The incidence of lymph node metastasis was 0% in group A, 10% in group B, 36.4% in group C and 57.1% in group D. The mean TCD scores (+/-SEM) of SESCC with lymph node metastasis were higher than that without (85.3 +/- 5.7, 16.3 +/- 3.9, respectively; P < 0.001). In group C, the TCD score of cases with lymph node metastases was higher than in those without lymph node metastasis (P < 0.001). E-cadherin expression was significantly reduced in the area of TCD compared with the SAM located over the TCD area (P < 0.001).
The TCD score is an important predictive marker for lymph node metastasis in SESCC. Clinical evaluation of TCD scores in endoscopic mucosal resection (EMR) specimens would enable accurate prediction of lymph node metastasis and extend the indication of EMR treatment for SESCC.
目前仍不清楚哪些参数对于预测浅表性食管鳞状细胞癌(SESCC)的转移潜能至关重要。因此,本文旨在研究SESCC中的肿瘤细胞解离(TCD)作为淋巴结转移的预测因素。
33例SESCC根据肿瘤浸润深度分为四组。未侵犯至黏膜肌层的癌归为A组;侵犯至黏膜肌层或上半黏膜下层不足三分之一的癌归为B组;侵犯至黏膜下层中层的癌归为C组;侵犯至下半黏膜下层三分之一的癌归为D组。TCD评分通过将TCD区域的长度除以固有层内或超出固有层的浸润区域的最大纵向长度,再乘以100来计算。在TCD区域和黏膜浸润癌的连续区域(SAM)中研究癌组织的E-钙黏蛋白表达。
A组淋巴结转移发生率为0%,B组为10%,C组为36.4%,D组为57.1%。有淋巴结转移的SESCC的平均TCD评分(±SEM)高于无淋巴结转移者(分别为85.3±5.7、16.3±3.9;P<0.001)。在C组中,有淋巴结转移的病例的TCD评分高于无淋巴结转移者(P<0.001)。与位于TCD区域上方的SAM相比,TCD区域的E-钙黏蛋白表达显著降低(P<0.001)。
TCD评分是SESCC淋巴结转移的重要预测标志物。在内镜黏膜切除术(EMR)标本中对TCD评分进行临床评估将能够准确预测淋巴结转移,并扩大SESCC的EMR治疗适应证。